Vanguard Group Inc Selecta Biosciences Inc Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SELB
# of Institutions
68Shares Held
41.4MCall Options Held
16.8KPut Options Held
0-
Artal Group S.A. Luxembourg, N49.14MShares$7.67 Million0.41% of portfolio
-
Black Rock Inc. New York, NY7.25MShares$6.09 Million0.0% of portfolio
-
Nano Dimension, Inc.3.79MShares$3.18 Million25.2% of portfolio
-
Geode Capital Management, LLC Boston, MA2.5MShares$2.1 Million0.0% of portfolio
-
State Street Corp Boston, MA2.09MShares$1.75 Million0.0% of portfolio
About SELECTA BIOSCIENCES INC
- Ticker SELB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 152,712,992
- Market Cap $128M
- Description
- Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...